Denali Therapeutics (DNLI) Net Margin (2018 - 2023)
Denali Therapeutics (DNLI) reported Net Margin of 7841.59% for Q3 2023, up 4829917.0% year-over-year from N/an in Q3 2022, and down 12676.92% on a QoQ basis from 62.35% in Q2 2023.
Denali Therapeutics (DNLI) has 6 years of Net Margin data on file, last reported at 7841.59% in Q3 2023.
- Quarterly Net Margin rose 4829917.0% year-over-year to 7841.59% in Q3 2023, while the trailing twelve-month figure through Jun 2024 was 33121.86% (down 3308404.0% YoY) and the FY2023 annual result came in at 43.94%, up 954968.0% from the prior year.
- Net Margin eased to 7841.59% in Q3 2023 per DNLI's latest filing, from 62.35% in the prior quarter.
- Across five years, Net Margin topped out at 77.3% in Q4 2020 and bottomed at 7004100.0% in Q1 2021.
- The 5-year median for Net Margin is 1004.93% (2020), against an average of 445058.95%.
- The widest annual swing landed in 2021, when Net Margin sank 689494038 bps; it then soared 700394220 bps in 2022.
- Tracing DNLI's Net Margin over 5 years: stood at 1236.26% in 2019, then jumped by 106 bps to 77.3% in 2020, then sank by 878 bps to 601.41% in 2021, then slumped by 64 bps to 986.78% in 2022, then sank by 695 bps to 7841.59% in 2023.
- Per Business Quant, the three latest DNLI Net Margin figures stand at 7841.59% (Q3 2023), 62.35% (Q2 2023), and 312.4% (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -7,841.59% |
| Jun 30, 2023 | 62.35% |
| Mar 31, 2023 | -312.40% |
| Dec 31, 2022 | -986.78% |
| Sep 30, 2022 | -56,140.76% |
| Jun 30, 2022 | -112.03% |
| Mar 31, 2022 | -157.80% |
| Dec 31, 2021 | -601.41% |
| Sep 30, 2021 | -1,600.53% |
| Jun 30, 2021 | -404.61% |
| Mar 31, 2021 | -7,004,100.00% |
| Dec 31, 2020 | 77.30% |
| Sep 30, 2020 | -1,164,560.00% |
| Jun 30, 2020 | -1,004.93% |
| Mar 31, 2020 | -109,159.62% |
| Dec 31, 2019 | -1,236.26% |
| Sep 30, 2019 | -48,187.50% |
| Jun 30, 2019 | -58,926.26% |
| Mar 31, 2019 | -927.28% |
| Dec 31, 2018 | 61.72% |
| Sep 30, 2018 | -2,959.92% |
| Jun 30, 2018 | -3,320.63% |
| Mar 31, 2018 | -4,016.85% |